🎉 M&A multiples are live!
Check it out!

Ocean Biomedical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ocean Biomedical and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

Ocean Biomedical Overview

About Ocean Biomedical

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.


Founded

2019

HQ

United States of America
Employees

7

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$24.0M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Ocean Biomedical Financials

Ocean Biomedical has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Ocean Biomedical achieved revenue of n/a and an EBITDA of -$7.4M.

Ocean Biomedical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Ocean Biomedical valuation multiples based on analyst estimates

Ocean Biomedical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$113M -$7.4M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit -$1.0M -$114M XXX XXX XXX
Net Margin -Infinity% -Infinity% XXX XXX XXX
Net Debt $1.8M $12.1M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Ocean Biomedical Stock Performance

As of April 15, 2025, Ocean Biomedical's stock price is $0.

Ocean Biomedical has current market cap of $7.7M, and EV of $24.0M.

See Ocean Biomedical trading valuation data

Ocean Biomedical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$24.0M $7.7M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Ocean Biomedical Valuation Multiples

As of April 15, 2025, Ocean Biomedical has market cap of $7.7M and EV of $24.0M.

Ocean Biomedical's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Ocean Biomedical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Ocean Biomedical and 10K+ public comps

Ocean Biomedical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $24.0M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -3.2x XXX XXX XXX
P/E -0.8x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -5.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ocean Biomedical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Ocean Biomedical Valuation Multiples

Ocean Biomedical's NTM/LTM revenue growth is n/a

Ocean Biomedical's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.5M for the same period.

Over next 12 months, Ocean Biomedical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Ocean Biomedical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Ocean Biomedical and other 10K+ public comps

Ocean Biomedical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -93% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.5M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Ocean Biomedical Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Ocean Biomedical M&A and Investment Activity

Ocean Biomedical acquired  XXX companies to date.

Last acquisition by Ocean Biomedical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Ocean Biomedical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Ocean Biomedical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Ocean Biomedical

When was Ocean Biomedical founded? Ocean Biomedical was founded in 2019.
Where is Ocean Biomedical headquartered? Ocean Biomedical is headquartered in United States of America.
How many employees does Ocean Biomedical have? As of today, Ocean Biomedical has 7 employees.
Who is the CEO of Ocean Biomedical? Ocean Biomedical's CEO is Dr. M. Michelle Berrey, M.D..
Is Ocean Biomedical publicy listed? Yes, Ocean Biomedical is a public company listed on NAS.
What is the stock symbol of Ocean Biomedical? Ocean Biomedical trades under OCEA ticker.
When did Ocean Biomedical go public? Ocean Biomedical went public in 2023.
Who are competitors of Ocean Biomedical? Similar companies to Ocean Biomedical include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Ocean Biomedical? Ocean Biomedical's current market cap is $7.7M
Is Ocean Biomedical profitable? Yes, Ocean Biomedical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.